Patients with glioblastoma with isocitrate dehydrogenase 1 (IDH1) mutation and ALT activation, which is associated with longer telomeres, showed better clinical outcome than those with ALT negative tumor [133,134,138-140]. The gene discussed is GPT; the disease is glioblastoma.